FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

Mutual Fund Sues Valeant Alleging it is a Criminal Enterprise

Sept. 6, 2017
A A

A mutual fund, citing $80 billion in losses on its investment in drugmaker Valeant, filed a lawsuit alleging securities violations, mail and wire fraud, and violations of the Racketeer Influenced and Corrupt Organizations Act (RICO).

Calling the company a “criminal enterprise,” Lord Abbett & Co named Valeant, its former CEO Michael Pearson, its accounting firm PwC (PricewaterhouseCoopers) and several other former executives in a civil securities fraud lawsuit against the company.

The fund notes in its lawsuit that Valeant bought more than 100 companies between 2008 and 2014. Valeant used a “deceptive business model” that relies on growth through acquisition, with those acquisitions targeting healthcare sectors largely free of competition, such as neurology, dermatology and ophthalmology, the lawsuit says.

View today's stories